A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
Open Access
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (12), 1343-1345
- https://doi.org/10.1023/a:1008469212268
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II studyAnti-Cancer Drugs, 1997
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.Journal of Clinical Oncology, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I studyAnnals of Oncology, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.Journal of Clinical Oncology, 1992
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978